• Amt-1, Nrf2/HO-1, and Influenza A Defense

  2026-10-06

  The reference study presents Amt-1 as an adamantane derivative with a dual antiviral and host-directed profile against influenza A virus. Its evidence connects residual M2 ion-channel interaction with Nrf2/HO-1 activation, reduced inflammatory signaling, lower lung viral burden, and improved outcomes in a mouse model, while leaving important translational questions unresolved.

• Dextrose and D-Glucose in Tumor Immunometabolism

  2026-10-06

  Dextrose, or D-glucose, is a central metabolic substrate in research on glycolysis, cellular energy production, and tumor–immune interactions. This overview examines how glucose availability is framed in hypoxic tumor microenvironments, what the current review evidence supports, and where conclusions remain limited by model complexity, study design, and clinical applicability.

• Aprotinin and the Translational Protease Lens

  2026-10-05

  A mechanistic and translational perspective on Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI), linking reversible serine protease control with fibrinolysis research, cardiovascular blood management, and carefully bounded applications in protease-aware transcriptomics.

• BCA Protein Quantification Kit K4102 Overview

  2026-10-05

  A concise, source-limited overview of APExBIO’s K4102 Bicinchoninic Acid Assay for research protein quantification, with no matched paper evidence.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Evidence Lens

  2026-10-04

  Explore how the FITC Goat Anti-Mouse IgG (H+L) Antibody supports interpretation of antiviral immunofluorescence and flow cytometry data. This article connects secondary-antibody signal biology with the Amt-1 influenza study while emphasizing evidence strength, assay boundaries, and translational relevance.

• Cy5 Maleimide in Condensate Biology

  2026-10-03

  A charge-aware perspective on using cysteine-selective Cy5 probes to study α-synuclein condensates, molecular partitioning, and translational biomarker questions.

• Cy5 amine (non-sulfonated) Labeling Protocol

  2026-10-02

  Cy5 amine (non-sulfonated), SKU A8143, provides a primary amino group for covalent attachment to compatible activated esters, activated carboxyl groups, or epoxides while supplying a near-red fluorescent readout. It is insoluble in water, so it should be dissolved in DMSO or ethanol before controlled transfer into an aqueous labeling workflow; it is not intended for diagnostic or medical use.

• Dihydroquercetin and Wnt/β-Catenin in Porcine Cells

  2026-10-01

  The reference study shows that dihydroquercetin (DHQ, taxifolin) promotes IPEC-J2 porcine intestinal epithelial cell proliferation while increasing tight-junction and proliferation-associated markers through Wnt/β-catenin signaling. Its inhibitor-based design connects a flavonoid treatment to a defined signaling mechanism, although the findings remain primarily an in vitro cell-model result.

• Cy5 maleimide (non-sulfonated): Practical Guide

  2026-10-01

  Cy5 maleimide (non-sulfonated) is a thiol-reactive labeling reagent for attaching a far-red fluorophore to cysteine-containing peptides and proteins through stable thioether bonds. It is appropriate for workflows that can manage low aqueous solubility and accessible thiols, but it is not a good choice when the target lacks reactive cysteines or direct dissolution in water is required.

• Protease Inhibitor Cocktail for OXPHOS Assays

  2026-09-30

  Learn how the Protease Inhibitor Cocktail preserves protein integrity in OXPHOS cancer workflows. This evidence-aware guide connects LRPPRC–dasatinib biology with practical extraction, assay selection, and EDTA-free sample handling.

• Ruxolitinib Phosphate: From JAK1/2 to Tumor Fate

  2026-09-30

  Ruxolitinib phosphate (INCB018424) offers translational researchers a precise way to connect JAK1/JAK2 inhibition with mitochondrial dynamics, apoptosis, and pyroptosis while preserving relevance to inflammatory and autoimmune disease models.

• ARCA Cy5 EGFP mRNA: A Readout Architecture

  2026-09-29

  ARCA Cy5 EGFP mRNA (5-moUTP) enables a dual-readout strategy for separating mRNA delivery, localization, and translation. This article explains how cap biology, Cy5 tracking, EGFP expression, and immune-response controls can improve interpretation of mammalian-cell delivery studies.

• From Sulfo-Cy5 Chemistry to Mucosal Vaccine Insight

  2026-09-29

  A translational framework for using Sulfo-Cy5 carboxylic acid to interrogate nanoparticle biodistribution, mucosal targeting, and immune-response mechanisms without overstating preclinical evidence.

• Cy5 Maleimide for Condensate Assays

  2026-09-28

  Cy5 maleimide enables site-specific cysteine labeling for sensitive protein and condensate assays. This guide explains how non-sulfonated Cy5 maleimide can report molecular partitioning while controlling for dye charge, solvent effects, and labeling-induced artifacts.

• JNJ-26481585 (Quisinostat) in Pituitary Tumor Research

  2026-09-28

  Use Quisinostat to investigate how broad HDAC inhibition intersects with TRIM21–ERK signaling and dopamine-agonist resistance in pituitary adenoma models. This practical workflow pairs early pathway readouts with proliferation and apoptosis assays so that changes in TRIM21 are not mistaken for proof of a specific mechanism.

8031 records 1/536 page Next 12345 下5页 Last page